The history of Viagra, and its parent company copyright, presents a intriguing case study for investors. Originally a blockbuster drug, yielding billions in income, its patent expiration created a flood of lower-priced alternatives , significantly eroding its dominance. While some pharmaceutical companies may attempt to capitalize on similar condit